98
Syversen U, Ramstad H, Gamme K, Qvigstad G, Falkmer S, Waldum HL (2004) Clinical signifi-
cance of elevated serum chromogranin A levels. Scand J Gastroenterol 39(10):969–973
Taupenot L, Harper KL, O’Connor DT (2003) The chromogranin-secretogranin family. N Engl
J Med 348(12):1134–1149
Tota B, Angelone T, Mazza R, Cerra MC (2008) The chromogranin A-derived vasostatins: new
players in the endocrine heart. Curr Med Chem 15(14):1444–1451
Turquier V, Vaudry H, Jegou S, Anouar Y (1999) Frog chromogranin A messenger ribonucleic
acid encodes three highly conserved peptides. Coordinate regulation of proopiomelanocortin
and chromogranin A gene expression in the pars intermedia of the pituitary during background
color adaptation. Endocrinology 140:4104–4112
Veschini L, Crippa L, Dondossola E, Doglioni C, Corti A, Ferrero E (2011) The vasostatin-1
fragment of chromogranin A preserves a quiescent phenotype in hypoxia-driven endothe-
lial cells and regulates tumor neovascularization. FASEB J 25(11):3906–3914. doi:10.1096/
fj.11-182410
Waldum HL, Brenna E (2000) Personal review: is profound acid inhibition safe? Aliment
Pharmacol Ther 14(1):15–22
Wallez Y, Huber P (2008) Endothelial adherens and tight junctions in vascular homeostasis,
inflammation and angiogenesis. Biochim Biophys Acta 1778(3):794–809. doi:10.1016/j.
bbamem.2007.09.003
Young RH, Srigley JR, Amin MB, Ulbright TM, Cubilla AL (2000) Carcinoma of the prostate
gland (excluding unusual variants and secondary carcinomas). In: Rosai J, Sobin LH (eds) Atlas
of tumor pathology, vol 28, 3rd series edn. Armed Forces Institute of Pathology, Washington
DC, pp 111–216
Zhang K, Rao F, Wen G, Salem RM, Vaingankar S, Mahata M, Mahapatra NR, Lillie EO, Cadman
PE, Friese RS, Hamilton BA, Hook VY, Mahata SK, Taupenot L, O'Connor DT (2006)
Catecholamine storage vesicles and the metabolic syndrome: the role of the chromogranin A
fragment pancreastatin. Diabetes Obes Metab 8(6):621–633
Zhang D, Lavaux T, Sapin R, Lavigne T, Castelain V, Aunis D, Metz-Boutigue MH, Schneider F
(2009) Serum concentration of chromogranin A at admission: an early biomarker of severity in
critically ill patients. Ann Med 41(1):38–44
F. Curnis et al.